Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prospect of Using Serum Taurine Level as a Potential Biomarker for Early Detection of Colorectal Carcinoma and Its Correlation With Other Prognostic Markers

NCT04192539 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT04192539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04192539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prospect of Using Serum Taurine Level as a Potential Biomarker for Early Detection of Colorectal Carcinoma and Its Correlation With Other Prognostic Markers
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
January 18, 2017
Completion date
December 17, 2018
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

taurine in cancer colon